Skip to main content

Table 1 Description of NSEBA study sites in Southern Province, Zambia, 2016–2018

From: Point-of-care p24 antigen detection for early infant diagnosis of HIV infection: cross-sectional and longitudinal studies in Zambia

Study site

Area

Type of area

Study period

(mm/yy)

Median (range) deliveries per week by women living with HIV

Median (range) DBS collected per week for EID

Eligible participants

Timing of follow-up

Staff trained to perform LYNX assay

Livingstone Central Hospital

Livingstone City

Urban

06/16–05/17

06/17–04/18

8 (1, 15)

N/A

All HEI

High-risk HEIa

Birth only

1 Research staffc

Maramba UHC

Livingstone City

Urban

06/16–05/17

06/17–04/18

3 (0, 12)

N/A

All HEI

High-risk HEIa

Birth only

1 Research staffc

Mahatma Gandhi UHC

Livingstone City

Urban

04/17–04/18

3 (0, 9)

N/A

High-risk HEIa

Birth only

1 Research staffc

Libuyu UHC

Livingstone City

Urban

04/17–04/18

1 (0, 5)

N/A

High-risk HEIa

Birth only

1 Research staffc

Choma General Hospital

Choma City

Urban

08/17–04/18

5 (2, 9)

N/A

High-risk HEIa

Birth only

2 Nurses

Shampande UHC

Choma City

Urban

08/17–04/18

2 (0, 5)

N/A

High-risk HEIa

Birth only

2 Nurses

Macha Hospital

Macha area

Rural

04/16–09/18

2 (0, 9)

3 (0, 11)

All HEI

Testing periodb

5 Counselors

6 Research staffc

Mapanza RHC

Macha area

Rural

04/16–09/18

0 (0, 4)

1 (0, 7)

All HEI

Testing periodb

1 Clinical Officer

2 Nurses

1 Counselor

Moboola RHC

Macha area

Rural

04/16–09/18

0 (0, 3)

1 (0, 7)

All HEI

Testing periodb

2 Nurses

1 Counselor

Mangunza RHC

Macha area

Rural

04/16–09/18

0 (0, 3)

1 (0, 5)

All HEI

Testing periodb

1 Nurse

1 Counselor

Nalube RHC

Macha area

Rural

04/16–07/17

0 (0, 2)

0 (0, 3)

All HEI

Testing periodb

1 Nurse

1 Counselor

  1. DBS Dried blood spots, EID Early infant diagnosis, HEI HIV-exposed infants, N/A Not applicable, RHC Rural health clinic, UHC Urban health center
  2. a High-risk defined as mothers receiving no antiretroviral drugs throughout pregnancy or starting to receive antiretroviral drugs during pregnancy to prevent mother-to-child transmission
  3. b Testing period includes any point of contact for early infant diagnosis testing from birth to post-weaning (e.g. birth, 6 weeks, 6 months, 12 months, 18 months, 24 months, post-weaning)
  4. c Research staff in Livingstone included 3 nurses; research staff in Macha included 1 nurse, 1 laboratory scientist, and 4 counselors by training